Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2018
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ataxia telangiectasia
- Focus Registrational; Therapeutic Use
- Acronyms ATTEST
- Sponsors EryDel
- 26 Dec 2017 This trial was suspended in Spain, according to European Clinical Trials Database.
- 06 Mar 2017 Status changed from not yet recruiting to recruiting, according to an EryDel media release.
- 20 Jan 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.